News Chart Oneness Biotech Co., Ltd.

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
156.5 ^TWD	-2.49%		+4.68%	-19.54%

May. 17	Oneness Biotech Co., Ltd. Agrees to Withdraw the 510(K) for Bonvadis Chronic Wound and Resubmit After the Supplementing Animal Study Data	CI
May. 09	US FDA Agrees Oneness Biotech Co., Ltd.'s S.C. Injection Formulation of FB825 to Proceed with Phase 2 Clinical Trial to Treat Moderate-To-Severe Atopic Dermatitis	CI

58130337ea7.Sk3NpwJK1WtllZv4q1K9nKTLyO4tTj8-vg1qmlic2cI.DRSi02Ymvlsj-9Oaz2vl-uCfsqlUJGhfj0k5zWjIuIguOJ_XQyOZBxGt-A~aafc8114343033cf1897804b9ed0d3af